Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma.
Safari M, Scotto L, Basseville A, Litman T, Xue H, Petrukhin L, Zhou P, Morales DV, Damoci C, Zhu M, Hull K, Olive KP, Fojo T, Romo D, Bates SE.
Safari M, et al. Among authors: hull k.
bioRxiv [Preprint]. 2024 Jul 2:2024.06.30.600495. doi: 10.1101/2024.06.30.600495.
bioRxiv. 2024.
PMID: 39005268
Free PMC article.
Preprint.